Logo
csv. check, some, votes

Objection pursuant to Rule 112: Extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (D061354)

Reference: B9-0103/2019

Date: 10.10.2019

Previous
Next
Filter by Country
Overall Result
Total: 751 MEPs
402 For
222 Against
39 Abstention
88 Did not vote
402 For
222 Against
39 Abstention
88 Did not vote
Jorge BUXADÉ VILLALBA
Foto von Jorge BUXADÉ VILLALBA

Country: Spain

Group: European Conservatives and Reformists (ECR)

Debate contributions: 47

My vote:
Did not vote